https://www.wesrch.com/medical/User_images/Pdf/Editorial_1210974035.pdf
Next

Maxims applied: How Pfizer's Maxim Violation with Nektar to develop and bring to market an inhaled insulin product called Exubera

  2080      Nov 30, -0001
It’s one of the most basic of maxims: that all marketing is based on needs, wants, features, and benefits. Where most go wrong, and Pfizer did so costly in this case study, is that they focus on features and wants because . . .
About weVISION: weQuest's are written by G Dan Hutcheson, his career spans more than thirty years, in which he became a well-known as a visionary for helping companies make businesses out of technology. This includes hundreds of successful programs involving product development, positioning, and launch in Semiconductor, Technology, Medicine, Energy, Business, High Tech, Enviorntment, Electronics, healthcare and Business devisions.

You may like this also:

...
01 October, 2019
...
30 September, 2019
OHWRC
28 September, 2019
Chad Serels
27 September, 2019
Emmanuel Faber
26 September, 2019

Aurinia Dry Eye Phase 2a Study Results

Both drugs were shown to be well-tolerated, exhibiting low drop discomfort scores. There was no statistical difference between VOS and Restasis® for the primary endpoint.

...
25 September, 2019
...
24 September, 2019
...
23 September, 2019

Recent weVISIONs

Open IC Design Platforms ... with Michael Wishart of Efabless
Michael WishartEfabless
20 August, 2019
Tom Caulfield on what's next at GLOBALFOUNDRIES
Tom CaulfieldGLOBALFOUNDRIES
22 July, 2019